XBiotech【XBIT】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

3.27

買値

3.20

売値

4.01

出来高

50,491

3.17 日の範囲 3.32

3.05 52 週間の範囲 9.96

時価総額

99.681M

前日終値

3.21

始値

3.17

時刻

872

3.27

(priorref)

最終取引時間

財務取引量

US$ 162,838

VWAP

3.2251

平均取引量 (3 か月)

72,047

発行済株式数

30,483,481

配当利回り

PER

-3.04

1 株当たり利益 (EPS)

-1.08

歳入

4.01M

純利益

-32.9M

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.xbiotech.com

本社

Austin, Texas, USA

設立

XBiotech Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker XBIT. The last closing price for XBiotech was US$3.21. Over the last year, XBiotech shares have traded in a share price range of US$ 3.05 to US$ 9.96.

XBiotech currently has 30,483,481 shares in issue. The market capitalisation of XBiotech is US$97.85 million. XBiotech has a price to earnings ratio (PE ratio) of -3.04.

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-0.30487804878	3.28	3.3899	3.05	61176	3.23932398	CS
4	-0.57	-14.84375	3.84	4	3.05	54017	3.44765091	CS
12	-3.39	-50.9009009009	6.66	7.64	3.05	72047	4.9610212	CS
26	-3.22	-49.6147919877	6.49	8.32	3.05	58812	5.90604121	CS
52	-2.73	-45.5	6	9.96	3.05	73101	6.5393077	CS
156	-6.97	-68.06640625	10.24	10.33	3	61209	5.88566281	CS
260	-13.39	-80.3721488595	16.66	25.8	3	94007	11.51173542	CS

XBIT - Frequently Asked Questions (FAQ)

What is the current XBiotech share price?

The current share price of XBiotech is US$ 3.27

How many XBiotech shares are in issue?

XBiotech has 30,483,481 shares in issue

What is the market cap of XBiotech?

The market capitalisation of XBiotech is USD 97.85M

What is the 1 year trading range for XBiotech share price?

XBiotech has traded in the range of US$ 3.05 to US$ 9.96 during the past year

What is the PE ratio of XBiotech?

The price to earnings ratio of XBiotech is -3.04

What is the cash to sales ratio of XBiotech?

The cash to sales ratio of XBiotech is 24.94

What is the reporting currency for XBiotech?

XBiotech reports financial results in USD

What is the latest annual turnover for XBiotech?

The latest annual turnover of XBiotech is USD 4.01M

What is the latest annual profit for XBiotech?

The latest annual profit of XBiotech is USD -32.9M

What is the registered address of XBiotech?

The registered address for XBiotech is 5217 WINNEBAGO LN, AUSTIN, TX 78744, AUSTIN, TEXAS, 78744

What is the XBiotech website address?

The website address for XBiotech is www.xbiotech.com

Which industry sector does XBiotech operate in?

XBiotech operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
JTAIJet AI Inc	US$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	US$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M